1. Home
  2. AXSM vs BILL Comparison

AXSM vs BILL Comparison

Compare AXSM & BILL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXSM
  • BILL
  • Stock Information
  • Founded
  • AXSM 2012
  • BILL 2006
  • Country
  • AXSM United States
  • BILL United States
  • Employees
  • AXSM N/A
  • BILL N/A
  • Industry
  • AXSM Biotechnology: Pharmaceutical Preparations
  • BILL EDP Services
  • Sector
  • AXSM Health Care
  • BILL Technology
  • Exchange
  • AXSM Nasdaq
  • BILL Nasdaq
  • Market Cap
  • AXSM 5.1B
  • BILL 4.7B
  • IPO Year
  • AXSM 2015
  • BILL 2019
  • Fundamental
  • Price
  • AXSM $116.78
  • BILL $51.60
  • Analyst Decision
  • AXSM Strong Buy
  • BILL Buy
  • Analyst Count
  • AXSM 17
  • BILL 21
  • Target Price
  • AXSM $175.76
  • BILL $59.90
  • AVG Volume (30 Days)
  • AXSM 591.0K
  • BILL 5.2M
  • Earning Date
  • AXSM 11-11-2025
  • BILL 11-06-2025
  • Dividend Yield
  • AXSM N/A
  • BILL N/A
  • EPS Growth
  • AXSM N/A
  • BILL N/A
  • EPS
  • AXSM N/A
  • BILL N/A
  • Revenue
  • AXSM $495,033,000.00
  • BILL $1,462,570,000.00
  • Revenue This Year
  • AXSM $64.05
  • BILL $12.40
  • Revenue Next Year
  • AXSM $56.46
  • BILL $13.69
  • P/E Ratio
  • AXSM N/A
  • BILL N/A
  • Revenue Growth
  • AXSM 69.83
  • BILL 13.36
  • 52 Week Low
  • AXSM $75.56
  • BILL $36.55
  • 52 Week High
  • AXSM $139.13
  • BILL $100.19
  • Technical
  • Relative Strength Index (RSI)
  • AXSM 47.95
  • BILL 63.81
  • Support Level
  • AXSM $123.54
  • BILL $50.95
  • Resistance Level
  • AXSM $130.00
  • BILL $54.97
  • Average True Range (ATR)
  • AXSM 3.66
  • BILL 2.28
  • MACD
  • AXSM -0.95
  • BILL 0.69
  • Stochastic Oscillator
  • AXSM 4.51
  • BILL 76.80

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

About BILL BILL Holdings Inc.

BILL Holdings Inc is a provider of software-as-a-service, cloud-based payments and spend and expense management products, which allow users to automate accounts payable and accounts receivable transactions, enable businesses to easily connect with their suppliers or customers to do business, eliminate expense reports, manage cash flows and improve back office efficiency. Initial Public Offering and Follow-on Offering.

Share on Social Networks: